Transfusion-related acute lung injury with anti-leukocyte antibodies identified both in patient's serum and in red cell concentrate

Masatoshi Nishizawa, Fumiya Hirayama, Nobuki Matsuyama, Kohei Tada, Hitomi Kaneko, Mitsumasa Watanabe, Yasuo Miura, Mitsuru Tsudo

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

We report a fatal case of transfusion-related acute lung injury (TRALI) with anti-leukocyte antibodies detected both in the patient's serum and in the causative red cell concentrate (RC-M.A.P). A 41-year-old Japanese woman diagnosed as having acute myeloid leukemia (AML, M2) developed TRALI caused by RC-M.A.P 15 days after the start of induction therapy for AML. Although we conducted intratracheal intubation, positive end-expiratory pressure ventilation, and steroid pulse therapy, she died 3 days after the onset of TRALI. We detected anti-human leukocyte antigen (HLA) class I antibody and anti-HLA class II antibody in the patient's serum and anti-neutrophil antibody in the RC-M.A.P, using the newly developed immunofluorescence tests with high specificity and low background interference. We assume that these anti-leukocyte antibodies were responsible for TRALI via an immune-mediated mechanism.

Original languageEnglish
Pages (from-to)16-22
Number of pages7
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume50
Issue number1
Publication statusPublished - 01-2009
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Transfusion-related acute lung injury with anti-leukocyte antibodies identified both in patient's serum and in red cell concentrate'. Together they form a unique fingerprint.

Cite this